Mitophagy is the selective degradation of mitochondria by autophagy. It often occurs to defective mitochondria following damage or stress. The process of mitophagy was first described over a hundred years ago by Margaret Reed Lewis and Warren Harmon Lewis. Ashford and Porter used electron microscopy to observe mitochondrial fragments in liver lysosomes by 1962, and a 1977 report suggested that "mitochondria develop functional alterations which would activate autophagy." The term "mitophagy" was in use by 1998.
Mitophagy is key in keeping the cell healthy. It promotes turnover of mitochondria and prevents accumulation of dysfunctional mitochondria which can lead to cellular degeneration. It is mediated by Atg32 (in yeast) and NIX and its regulator BNIP3 in mammals. Mitophagy is regulated by PINK1 and parkin proteins. In addition to the selective removal of damaged mitochondria, mitophagy is also required to adjust mitochondrial numbers to changing cellular metabolic needs, for steady-state mitochondrial turnover, and during certain cellular developmental stages, such as during cellular differentiation of red blood cells.
Organelles and bits of cytoplasm are sequestered and targeted for degradation by the lysosome for hydrolytic digestion by a process known as autophagy. Mitochondria metabolism leads to the creation of by-products that lead to DNA damage and mutations. Therefore, a healthy population of mitochondria is critical for the well-being of cells. Previously it was thought that targeted degradation of mitochondria was a stochastic event, but accumulating evidence suggest that mitophagy is a selective process.
Generation of ATP by oxidative phosphorylation leads to the production of various reactive oxygen species (ROS) in the mitochondria, and submitochondrial particles. Formation of ROS as a mitochondrial waste product will eventually lead to cytotoxicity and cell death. Because of their role in metabolism, mitochondria are very susceptible to ROS damage. Damaged mitochondria cause a depletion in ATP and a release of cytochrome c, which leads to activation of caspases and onset of apoptosis. Mitochondrial damage is not caused solely by oxidative stress or disease processes; normal mitochondria will eventually accumulate oxidative damage hallmarks overtime, which can be deleterious to mitochondria as well as to the cell. These faulty mitochondria can further deplete the cell from ATP, increase production of ROS, and release proapoptopic proteins such as caspases.
Because of the danger of having damaged mitochondria in the cell, the timely elimination of damaged and aged mitochondria is essential for maintaining the integrity of the cell. This turnover process consists of the sequestration and hydrolytic degradation by the lysosome, a process also known as mitophagy.
There are several pathways by which mitophagy is induced in mammalian cells. The PINK1 and Parkin pathway is, so far, the best characterized. This pathway starts by deciphering the difference between healthy mitochondria and damaged mitochondria. A 64-kDa protein, PTEN-induced kinase 1 (PINK1), has been implicated to detect mitochondrial quality. PINK1 contains a mitochondrial targeting sequence (MTS) and is recruited to the mitochondria. In healthy mitochondria, PINK1 is imported through the outer membrane via the TOM complex, and partially through the inner mitochondrial membrane via the TIM complex, so it then spans the inner mitochondrial membrane. The process of import into the inner membrane is associated with the cleavage of PINK1 from 64-kDa into 60-kDa. PINK1 is then cleaved by PARL into 52-kDa. This new form of PINK1 is degraded by proteases within the mitochondria. This keeps the concentration of PINK1 in check in healthy mitochondria.
In unhealthy mitochondria, the inner mitochondrial membrane becomes depolarized. This membrane potential is necessary for the TIM-mediated protein import. In depolarized mitochondria, PINK1 is no longer imported into the inner membrane, is not cleaved by PARL and PINK1 concentration increases in the outer mitochondrial membrane. PINK1 can then recruit Parkin, a cytosolic E3 ubiquitin ligase.. It is thought that PINK1 phosphorylates Parkin ubiquitin ligase at S65 which initiates Parkin recruitment at the mitochondria. Once localized at the mitochondria, PINK1 phosphorylates Parkin at S65, homologous to the site where ubiquitin was phosphorylated, which activates Parkin by inducing dimerization and an active state. This allows for Parkin mediated ubiquitination on other proteins.
Because of the PINK1 mediated recruitment to the mitochondrial surface, Parkin can ubiquitylate proteins in the outer mitochondrial membrane. Some of these proteins include Mfn1/Mfn2 and mitoNEET. The ubiquitylation of mitochondrial surface proteins brings in mitophagy initiating factors. Parkin promotes ubiquitin chain linkages on both K63 and K48. K48 ubiquitination initiates degradation of the proteins, and could allow for passive mitochondrial degradation. K63 ubiquitination is thought to recruit autophagy adaptors LC3/GABARAP which will then lead to mitophagy. It is still unclear which proteins are necessary and sufficient for mitophagy, and how these proteins, once ubiquitylated, initiate mitophagy.
Other pathways that can induce mitophagy includes mitophagy receptors on the outer mitochondrial membrane surface. These receptors include NIX1, BNIP3 and FUNDC1. All of these receptors contain LIR consensus sequences that bind LC3/GABARAP which can lead to the degradation of the mitochondria. In hypoxic conditions BNIP3 is upregulated by HIF1α. BNIP3 is then phosphorylated at its serine residues near the LIR sequence which promotes LC3 binding. FUNDCI is also hypoxia sensitive, although it is constitutively present at the outer mitochondrial membrane during normal conditions 
In neurons, mitochondria are distributed unequally throughout the cell to areas where energy demand is high, like at synapses and Nodes of Ranvier. This distribution is maintained largely by motor protein-mediated mitochondrial transport along the axon. While neuronal mitophagy is thought to occur primarily in the cell body, it also occurs locally in the axon at sites distant from the cell body; in both the cell body and the axon, neuronal mitophagy occurs via the PINK1-Parkin pathway. Mitophagy in the nervous system may also occur transcellularly, where damaged mitochondria in retinal ganglion cell axons can be passed to neighboring astrocytes for degradation. This process is known as transmitophagy.
Mitophagy in yeast was first presumed after the discovery of Yeast Mitochondrial Escape genes (yme), specifically yme1. Yme1 like other genes in the family showed increase escapes of mtDNA, but was the only one that showed in increase in mitochondrial degradation. Through work on this gene that mediates the escape of mtDNA, researchers discovered that mitochondrial turnover is triggered by proteins.
More was discovered about genetic control of mitophagy after studies done of UTH1. After doing a screen for genes that regulate longevity. It was found in ΔUTH1 strains there was an inhibition of mitophagy, which occurred without affecting autophagy mechanisms. It also showed that Uth1p protein is necessary to move mitochondria to the vacuole. This suggested there is a specialized system for mitophagy. Other studies looked at AUP1, a mitochondrial phosphatase, and found Aup1 marks mitochondria for elimination.
Another yeast protein associated with mitophagy is a mitochondrial inner membrane protein, Mdm38p/Mkh1p. This protein is part of the complex that exchanges K+/H+ ions across the inner membrane. Deletions to this protein causes swelling, a loss of membrane potential, and mitochondrial fragmentation.
Recently, it has been shown that ATG32 (autophagy related gene 32) plays a crucial role in yeast mitophagy. It is localized to the mitochondria. Once mitophagy is initiated, Atg32 binds to Atg11 and the Atg32-associated mitochondria is transported to the vacuole. Atg32 silencing stops recruitment of autophagy machinery and mitochondrial degradation. Atg32 is not necessary for other forms of autophagy.
All of these proteins likely play a role in maintaining a healthy mitochondria, but mutations have shown that dysregulation can lead to a selective degradation of mitochondria. Whether these proteins work in concert, are main players in mitophagy, or the networks controlled still remain to be elucidated
Relation to disease
As of 2020, the role of mitophagy in cancer is not fully understood. Some models of mitophagy, such as PINK1 or BNIP3-mediated mitophagy, have been associated with tumor suppression in humans and mice. Mitophagy associated with NIX, in contrast, is associated with tumor promotion. In 1920 Otto Warburg observed that certain cancerous tumors display a metabolic shift towards glycolysis. This is referred to as the "Warburg effect", in which cancer cells produce energy via the conversion of glucose into lactate, even in the presence of oxygen (aerobic glycolysis). Despite nearly a century since it was first described, a lot of questions remained unanswered regarding the Warburg effect. Initially, Warburg attributed this metabolic shift to mitochondrial dysfunction in cancer cells. Further studies in tumor biology have shown that the increased growth rate in cancer cells is due to an overdrive in glycolysis (glycolytic shift), which leads to a decrease in oxidative phosphorylation and mitochondrial density. As a consequence of the Warburg effect, cancer cells would produce large amounts of lactate. The excess lactate is then released to the extracellular environment which results in a decrease in extracellular pH. This micro-environment acidification can lead to cellular stress, which would lead to autophagy. Autophagy is activated in response to a range of stimuli, including nutrient depletion, hypoxia, and activated oncogenes. However, it appears that autophagy can help in cancer cell survival under conditions of metabolic stress and it may confer resistance to anti-cancer therapies such as radiation and chemotherapy. Additionally, in the microenvironment of cancer cells, there is an increase in hypoxia-inducible transcription factor 1-alpha (HIF1A), which promotes expression of BNIP3, an essential factor for mitophagy.
Parkinson's disease is a neurodegenerative disorder pathologically characterized by death of the dopamine-producing neurons in the substantia nigra. There are several genetic mutations implicated in Parkinson's disease, including loss of function PINK1  and Parkin. Loss of function in either of these genes results in accumulation of damaged mitochondria and aggregation of proteins – eventually leading to neuronal death.
Mitochondria dysfunction is thought to be involved in Parkinson's disease pathogenesis. In spontaneous, usually aging related Parkinson's disease (non-genetically linked), the disease is commonly caused by dysfunctional mitochondria, cellular oxidative stress, autophagic alterations and the aggregation of proteins. These can lead to mitochondrial swelling and depolarization. It is important to keep the dysfunctional mitochondria regulated, because all of these traits could be induced by mitochondrial dysfunction and can induce cell death. Disorders in energy creation by mitochondria can cause cellular degeneration, like those seen in the substantia nigra.
- Lewis, Margaret; Lewis, Warren (1915). "Mitochondria (and other cytoplamic structures) in tissue cultures" (PDF). American Journal of Anatomy. 17 (3): 339–401. doi:10.1002/aja.1000170304.
- Ashford, TP; Porter, KR (1962). "Cytoplasmic components of hepatic cell lysosomes". The Journal of Cell Biology. 12: 198–202. doi:10.1083/jcb.12.1.198. PMC 2106008. PMID 13862833.
- Beaulaton, J; Lockshin, KR (1977). "Ultrastructural study of the normal degeneration of the intersegmental muscles of Anthereae polyphemus and Manduca sexta (Insecta, Lepidoptera) with particular reference of cellular autophagy". Journal of Morphology. 154: 39–57. doi:10.1002/jmor.1051540104. PMID 915948.
- Scott, SV; Klionsky, DJ (1988). "Delivery of Proteins and organelles to the vacuole from the cytoplasm". Current Opinion in Cell Biology. 10 (4): 523–529. doi:10.1016/S0955-0674(98)80068-9. PMID 9719874.
- Youle, R; Narendra, D (2011). "Mechanisms of mitophagy". Nature Reviews Molecular Cell Biology. 12 (1): 9–14. doi:10.1038/nrm3028. PMC 4780047. PMID 21179058.
- Kim, I; et al. (2007). "Selective degradation of mitochondria by mitophagy". Archives of Biochemistry and Biophysics. 462 (2): 245–256. doi:10.1016/j.abb.2007.03.034. PMC 2756107. PMID 17475204.
- Correia-Melo C, Marques FD, Anderson R, Hewitt G, Hewitt R, Cole J, Carroll BM, Miwa S, Birch J, Merz A, Rushton MD, Charles M, Jurk D, Tait SW, Czapiewski R, Greaves L, Nelson G, Bohlooly-Y M, Rodriguez-Cuenca S, Vidal-Puig A, Mann D, Saretzki G, Quarato G, Green DR, Adams PD, von Zglinicki T, Korolchuk VI, Passos JF (2016). "Mitochondria are required for pro-ageing features of the senescent phenotype". The EMBO Journal. 35 (7): 724–42. doi:10.15252/embj.201592862. PMC 4818766. PMID 26848154.
In multiple models of senescence, absence of mitochondria reduced a spectrum of senescence effectors and phenotypes while preserving ATP production via enhanced glycolysis.
- Jin, SM; Youle, RJ (2012). "PINK1- and Parkin-mediated mitophagy at a glance". J Cell Sci. 125 (4): 795–9. doi:10.1242/jcs.093849. PMC 3656616. PMID 22448035.
- Kitada, T; Asakawa, S; Hattori, N; et al. (1998). "Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism". Nature. 392 (6676): 605–8. doi:10.1038/33416. PMID 9560156.
- Lazarou M. "Keeping the immune system in check: a role for mitophagy. Immunol Cell Biol. 2014;
- Kane, LA; Lazarou, M; Fogel, AI; et al. (2014). "PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity". J Cell Biol. 205 (2): 143–53. doi:10.1083/jcb.201402104. PMC 4003245. PMID 24751536.
- Narendra, D; Tanaka, A; Suen, DF; Youle, RJ (2009). "Parkin-induced mitophagy in the pathogenesis of Parkinson disease". Autophagy. 5 (5): 706–8. doi:10.4161/auto.5.5.8505. PMID 19377297.
- Saxton, William M.; Hollenbeck, Peter J. (2012). "The axonal transport of mitochondria". Journal of Cell Science. 125 (9): 2095–2104. doi:10.1242/jcs.053850. PMC 1533994. PMID 16306220.
- Ashrafi G, Schlehe JS, Lavoie MJ, Schwartz TL (2014). "Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin". J Cell Biol. 206 (5): 655–70. doi:10.1083/jcb.201401070. PMC 4151150. PMID 25154397.
- Davis CH, Kim KY, Bushong EA, Mills EA, Boassa D, Shih T, Kinebuchi M, Phan S, Zhou Y, Bihlmeyer NA, Nguyen JV, Jin Y, Ellisman MH, Marsh-Armstrong N (2014). "Transcellular degradation of axonal mitochondria". Proc Natl Acad Sci U S A. 111 (26): 9633–8. doi:10.1073/pnas.1404651111. PMC 4084443. PMID 24979790.
- Tolkovsky, AM (2009). "Mitophagy". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1793 (9): 1508–15. doi:10.1016/j.bbamcr.2009.03.002. PMID 19289147.
- Kanki, T; et al. (2009). "Atg32 is a mitochondrial protein that confers selectivity during mitophagy". Dev Cell. 17 (1): 98–109. doi:10.1016/j.devcel.2009.06.014. PMC 2746076. PMID 19619495.
- Vives-Bauza, C; Przedborski, S (2011). "Mitophagy: the latest problem for Parkinson's disease". Trends Mol Med. 17 (3): 158–65. doi:10.1016/j.molmed.2010.11.002. PMID 21146459.
- MacLeod, Kay F. (2020). "Mitophagy and Mitochondrial Dysfunction in Cancer". Annual Review of Cancer Biology. 4: 41–60. doi:10.1146/annurev-cancerbio-030419-033405.
- Pavlides, S; et al. (2012). "Warburg Meets Autophagy: Cancer-Associated Fibroblasts Accelerate Tumor Growth and Metastasis via Oxidative Stress, Mitophagy, and Aerobic Glycolysis". Antioxidants & Redox Signaling. 16 (11): 1264–1284. doi:10.1089/ars.2011.4243. PMC 3324816. PMID 21883043.
- Valente, EM; Abou-sleiman, PM; Caputo, V; et al. (2004). "Hereditary early-onset Parkinson's disease caused by mutations in PINK1". Science. 304 (5674): 1158–60. doi:10.1126/science.1096284. PMID 15087508.
- Esteves, AR; Arduíno, DM; Silva, DF; Oliveira, CR; Cardoso, SM (2011). "Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD". Parkinson's Disease. 2011: 693761. doi:10.4061/2011/693761. PMC 3026982. PMID 21318163.
- Arduíno, DM; Esteves, AR; Cardoso, SM (2011). "Mitochondrial fusion/fission, transport and autophagy in Parkinson's disease: when mitochondria get nasty". Parkinson's Disease. 2011: 767230. doi:10.4061/2011/767230. PMC 3043324. PMID 21403911.